The 14 references in paper В. Парфенов А., С. Вербицкая В. (2016) “ПРОФИЛАКТИКА ПОВТОРНОГО НЕКАРДИОЭМБОЛИЧЕСКОГО ИШЕМИЧЕСКОГО ИНСУЛЬТА НА ОСНОВЕ АНТИТРОМБОЦИТАРНЫХ СРЕДСТВ” / spz:neicon:aterotromboz:y:2016:i:2:p:89-97

1
Парфенов В.А., Хасанова Д.Р. Ишемический инсульт. М.: МИА, 2012. 288 с.
(check this in PDF content)
2
Sacco RL, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37: 577-617.
(check this in PDF content)
3
European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis,2008, 25: 457-507.
(check this in PDF content)
4
Furie KL, Kasner SE, Adams RJ et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2011, 42: 227-276.
(check this in PDF content)
5
Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2014, published online May 1, DOI: 10.1161/STR.0000000000000024
(check this in PDF content)
6
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324: 71-86.
(check this in PDF content)
7
The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med, 1978, 299: 53-59.
(check this in PDF content)
8
CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet, 1997, 349: 1641-1649.
(check this in PDF content)
9
International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet, 1997, 349: 1569-1581.
(check this in PDF content)
10
Weisman SM, Graham DY. Evaluation of the benefits and risks of lowdose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med, 2002, 162: 2197-2202.
(check this in PDF content)
11
The ESPS Group. The European Stroke Prevention Study: principal endpoints. Lancet, 1987, 2: 1351-1354.
(check this in PDF content)
12
Diener HC, Cunha L, Forbes C et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci, 1996, 143: 1-13.
(check this in PDF content)
13
The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet, 2006, 367: 1665-1673.
(check this in PDF content)
14
Dengler R, Diener HC, Schwartz A et al. EARLY Investigators. Early treatment with aspirin plus extendedrelease dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, openlabel, blinded-endpoint trial. Lancet Neurol, 2010, 9:
(check this in PDF content)